Positron emission tomography facilitates diagnosis of early-onset Alzheimer's disease

European Neurology

Volumn 59, Issue 1-2, 2007, Pages 31-37

  McMurtray, Aaron M ^a,b   Licht, Eliot ^a,b   Yeo, Tuty ^a   Krisztal, Erica ^a   Saul, Ronald E ^a,b   Mendez, Mario F ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

Author keywords

Alzheimer's disease; Dementia; Positron emission tomography; Sensitivity

Indexed keywords

ADULT; ALZHEIMER DISEASE; ARTICLE; CASE CONTROL STUDY; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROL GROUP; CONTROLLED STUDY; CORRELATION ANALYSIS; EARLY DIAGNOSIS; FEMALE; FRONTAL LOBE; HUMAN; MALE; MEMORY DISORDER; METABOLIC DISORDER; ONSET AGE; PARIETAL LOBE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TEMPORAL LOBE;

ALZHEIMER DISEASE; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MENTAL STATUS SCHEDULE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; POSITRON-EMISSION TOMOGRAPHY; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 37249064623     PISSN: 00143022     EISSN: None     Source Type: Journal    
DOI: 10.1159/000109258     Document Type: Article

References (31)

1. Mendez MF, Cummings JL: Dementia: A Clinical Approach, ed 3. Philadelphia, Elsevier Science Publishing, 2003.
2. Silverman DH, Small GW, Chang CY, Lu CS, Kung De Aburto MA, Chen W, Czernin J, Rapoport SI, Pietrini P, Alexander GE, Schapiro MB, Jaqust WJ, Hoffman JM, Welsh-Bohmer KA, Alavi A, Clark CM, Salmon E, de Leon MJ, Mielke R, Cummings JL, Kowell AP, Gambhir SS, Hoh CK, Phelps ME: Positron emission tomography in the evaluation of dementia: regional brain metabolism and long-term outcome. JAMA 2001; 286:2120-2127.
3. Silverman D, Truong C, Kim S, Chang CY, Chen W, Kowell AP, Cummings JL, Czernin J, Small GW, Phelps ME: Prognostic value of regional cerebral metabolism in patients undergoing dementia evaluation: comparison to a quantifying parameter of subsequent cognitive performance and to prognostic assessment without PET. Mol Genet Metab 2003;80:350-355.
4. Minoshima S, Giordani B, Berent S, Frey KA, Foster NL, Kuhl DE: Metabolic reduction in the posterior cingulated cortex in very early Alzheimer's disease. Ann Neurol 1997;42:85-94.
5. Folstein MF, Folstein SE, McHugh PR: 'Minimental state': a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
6. Morris JC, Heyman A, Mohs RC, Hughes JP, van Belle G, Fillenbaum G, Mellits ED, Clark C: The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part 1. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology 1989;9:1159-1165.
7. Morris JC: The clinical dementia rating (CDR): current version and scoring rules. Neurology 1993;43:2412-2414.
8. McKhann G, Drachman DD, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
9. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 4 (text rev). Washington, American Psychiatric Association Press, 2000.
10. Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO, Nordberg A, Backman L, Albert M, Almkvist O, Arai H, Basun H, Blennow K, de Leon M, DeCarli C, Erkinjuntti T, Giacobini E, Graff C, Hardy J, Jack C, Jorm A, Ritchie K, van Duijn C, Visser P, Petersen RC: Mild cognitive impairment - beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med 2004;256:240-246.
11. Devous MD Sr: Functional brain imaging in the dementias: role in early detection, differential diagnosis, and longitudinal studies. Eur J Nucl Med Mol Imaging 2002;29:1685-1696.
12. Zakzanis KK, Graham SJ, Campbell Z: A meta-analysis of structural and functional brain imaging in dementia of the Alzheimer's type: a neuroimaging profile. Neuropsychol Rev 2003;13:1-18.
13. Azari NP, Pettigrew KD, Schapiro MB, Haxby JV, Grady CL, Pietrini P, Salerno P, Salerno JA, Heston LL, Rapoport SI, Horwitz B: Early detection of Alzheimer's disease: a statistical approach using positron emission tomographic data. J Cereb Blood Flow Metab 1993;13:438-447.
14. Haxby JV, Grady CL, Koss E, Horwitz B, Heston L, Schapiro M, Friedland RP, Rapoport SI: Longitudinal study of cerebral metabolic asymmetries and associated neuropsychological patterns in early dementia of the Alzheimer type. Arch Neurol 1990;47:753-760.
15. Zamrini E, De Santi S, Tolar M: Imaging is superior to cognitive testing for early diagnosis of Alzheimer's disease. Neurobiol Aging 2004;25:685-691.
16. Silverman DH, Gambhir SS, Huang HW, Schwimmer J, Kim S, Small GW, Chodosh J, Czernin J, Phelps ME: Evaluating early dementia with and without assessment of regional cerebral metabolism by PET: a comparison of predicted costs and benefits. J Nucl Med 2002;43:253-266.
17. Chetelat G, Desgranges B, de la Sayette V, Viader F, Eustache F, Baron JC: Mild cognitive impairment: can FDG-PET predict who is to rapidly convert to Alzheimer's disease? Neurology 2003;60:1374-1377.
18. Arnaiz E, Jelic V, Almkvist O, Wahlund LO, Winblad B, Valind S, Nordberg A: Impaired cerebral glucose metabolism and cognitive functioning predict deterioration in mild cognitive impairment. Neuroreport 2001;12:851-855.
19. Mosconi L, Perani D, Sorbi S, Herholz K, Nacmias B, Holthoff V, Salmon E, Baron JC, De Cristofaro MT, Padovani A, Borroni B, Franceschi M, Bracco L, Pupi A: MCI conversion to dementia and the APOE genotype: a prediction study with FDG-PET. Neurology 2004;63:2332-2340.
20. Panegyres PK, Davies SR, Connor CF: Earlyonset dementia. Med J Aust 2000;173:279-280.
21. Harvey RJ, Roques P, Fox NC, Rossor MN: Non-Alzheimer dementias in young patients. Br J Psychiatry 1996;168:384-385.
22. Harvery RJ, Skelton-Robinson M, Rossor MN: The prevalence and causes of dementia in people under the age of 65 years. J Neurol Neurosurg Psychiatry 2003;74:1206-1209.
23. Fujihara S, Brucki SM, Rocha MS, Carvalho AA, Piccolo AC: Prevalence of presenile dementia in a tertiary outpatient clinic. Arq Neuropsiquiatr 2004;62:592-595.
24. McMurtray AM, Clark DG, Christine D, Mendez MF: Early-onset dementia: frequency and causes compared to late-onset dementia. Dement Geriatr Cogn Disord 2006;21:59-64.
25. Small GW, Kuhl DE, Riege WH, Fujikawa DG, Ashford JW, Metter EJ, Mazziotta JC: Cerebral glucose metabolic patterns in Alzheimer's disease: effect of gender and age at dementia onset. Arch Gen Psychiatry 1989;46:527-532.
26. Koss E, Friedland RP, Ober BA, Jagust WJ: Differences in lateral hemispheric asymmetries of glucose utilization between earlyand late-onset Alzheimer-type dementia. Am J Psychiatry 1985;142:638-640.
27. Kalpouzos G, Eustache F, de la Sayette V, Viader F, Chetelat G, Desgranges B: Working memory and FDG-PET dissociate early and late onset Alzheimer disease patients. J Neurol 2005;252:548-558.
28. Kim EJ, Cho SS, Jeong Y, Park KC, Kang SJ, Kang E, Kim SE, Lee KH, Na DL: Glucose metabolism in early onset versus late onset Alzheimer's disease: an SPM analysis of 120 patients. Brain 2005;128:1790-1801.
29. Mosconi L, Sorbi S, de Leon MJ, Li Y, Nacmias B, Myoung PS, Tsui W, Ginestroni A, Bessi V, Fayyazz M, Caffarra P, Pupi A: Hypometabolism exceeds atrophy in presymptomatic early-onset familial Alzheimer's Disease. J Nucl Med 2006;47:1778-1786.
30. Chui H, Zhang Q: Evaluation of dementia: a systematic study of the usefulness of the American Academy of Neurology's practice parameters. Neurology 1997;49:925-935.
31. Knopman DS, DeKosky ST, Cummings JL, Chui H, Corey-Bloom J, Relkin N, Small GW, Miller B, Stevens JC: Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001;56:1143-1153.